0000000001296343

AUTHOR

Niccolò Allievi

showing 1 related works from this author

Can sentinel node biopsy be safely omitted in thin melanoma? Risk factor analysis of 1272 multicenter prospective cases

2019

Background: The indication to sentinel node biopsy (SNB) for thin melanomas (Breslow <1 mm) is still subject to controversies. The aim of this paper is to review all SNB performed for thin melanoma and to analyze factors related to lymphatic metastasis. Moreover, the diagnostic performance of the 5th, 6th, 7th and 8th AJCC classifications for cutaneous melanoma were investigated. Methods: All sentinel node biopsies performed for thin melanomas were selected from a multicentre prospectively-collected database. For each patient the following was collected: age, sex, date of treatment, site of primary melanoma, histopathologic features (Breslow, Clark, number of mitoses/mm2 , presence of ul…

Malemedicine.medical_specialtySkin NeoplasmsMultivariate analysisRisk AssessmentBreslow Thickness03 medical and health sciencesMelanoma; Sentinel node; Sentinel node biopsy; Thin melanoma0302 clinical medicineRisk FactorsBiopsyHumansMedicineProspective Studies030212 general & internal medicineSkin NeoplasmRisk factorProspective cohort studyMelanomaThin melanomaSentinel node biopsyMelanoma; Sentinel node; Sentinel node biopsy; Thin melanoma; Surgery; Oncologymedicine.diagnostic_testbusiness.industrySentinel Lymph Node BiopsyMelanomaRisk FactorLymphatic MetastasiGeneral MedicineSentinel nodeMiddle Agedmedicine.diseaseProspective StudieOncologySentinel nodeLymphatic Metastasis030220 oncology & carcinogenesisCutaneous melanomaSurgeryFemaleRadiologybusinessHuman
researchProduct